Mitch A. Phelps
机构: The Ohio State University
每年引用次数
引用次数
引用: 7,768
H-指数: 42
I10-指数 : 116
出版物: 303
Risk Factors for Tumor Lysis Syndrome (TLS) In Patients with Chronic Lymphocytic Leukemia (CLL) Treated with the Cyclin Dependent Kinase Inhibitor, Flavopiridol.
Kristie A. Blum , Amy S. Ruppert , Jennifer A. Woyach , Jeffrey A. Jones
Blood 116 ( 21) 1386 -1386
2010
Flavopiridol Treatment of Patients Aged 70 or Older with Refractory or Relapsed Chronic Lymphocytic Leukemia Is Feasible and Not Associated with Adverse Outcome When Compared to Younger Patients
Deborah M Stephens , Amy S. Ruppert , Kristie A. Blum , Jeffrey A. Jones
Blood 116 ( 21) 1378 -1378
1
2010
Phase 1 Trial of Flavopiridol and Lenalidomide In Patients with Previously Treated Chronic Lymphocytic Leukemia (CLL)
Kristie A. Blum , Jeffrey A. Jones , Leslie Andritsos , Joseph M. Flynn
Blood 116 ( 21) 2472 -2472
7
2010
Site Specific Discrete PEGylation of 124I-Labeled mCC49 Fab′ Fragments Improves Tumor MicroPET/CT Imaging in Mice
Haiming Ding , Michelle M. Carlton , Stephen P. Povoski , Keisha Milum
Bioconjugate Chemistry 24 ( 11) 1945 -1954
14
2013
Activity of Combined Flavopiridol and Lenalidomide in Patients with Cytogenetically High Risk Chronic Lymphocytic Leukemia (CLL): Updated Results of a Phase I Trial,
Kristie A. Blum , Lai Wei , Jeffrey A. Jones , Leslie A Andritsos
Blood 118 ( 21) 3910 -3910
4
2011
Results of A Phase I Study of Milatuzumab, a Humanized Anti-CD74 Antibody, and Veltuzumab, a Humanized Anti-CD20 Antibody, In Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma
Beth Christian , Lapo Alinari , Jeffrey A Jones , Don M Benson Jr
Blood 118 ( 21) 3707 -3707
2
2011
Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networks.
Jennifer M Thomas-Ahner , Samuel K Kulp , Zhiliang Xie , Mitch A Phelps
Scientific Reports 11 ( 1) 3646 -3646
7
2021
Replication Study: Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs.
Hongyan Wang , Hanna S Radomska , Mitch A Phelps , Reproducibility Project: Cancer Biology
eLife 9
1
2020
Institutional Profile: Program in Pharmacogenomics at the Ohio State University Medical Center
Joseph P Kitzmiller , Peter J Embi , Kandamurugu Manickam , Kevin M Sweet
Pharmacogenomics 13 ( 7) 751 -756
2
2012
Modeling of active transport systems
Eric Y Zhang , Mitch A Phelps , Chang Cheng , Sean Ekins
Advanced Drug Delivery Reviews 54 ( 3) 329 -354
68
2002
Development and validation of a highly sensitive liquid chromatography/mass spectrometry method for simultaneous quantification of lenalidomide and flavopiridol in human plasma.
Qing Liu , Katherine L Farley , Amy J Johnson , Natarajan Muthusamy
Therapeutic Drug Monitoring 30 ( 5) 620 -627
29
2008
Introducing a novel DHODH inhibitor with superior in vivo activity as monotherapy or in novel combination regimen with immunotherapy for hematological malignancies
Ola A Elgamal , Sandip Vibhute , Sydney Fobare , Abeera Mehmood
Cancer Research 82 ( 12\_Supplement) 1060 -1060
2022
DNA origami nanostructures elicit dose-dependent immunogenicity and are nontoxic up to high doses In vivo
Christopher R Lucas , Patrick D Halley , Amjad A Chowdury , Bonnie K Harrington
Small 18 ( 26) 2108063
13
2022
The Extracellular RNA Communication Consortium: Establishing Foundational Knowledge and Technologies for Extracellular RNA Research
Saumya Das , Asim B Abdel-Mageed , Catherine Adamidi , P David Adelson
Cell 177 ( 2) 231 -242
127
2019
Discovery of anticancer agents of diverse natural origin
Leslie N Aldrich , Joanna E Burdette , Esperanza Carcache de Blanco , Christopher C Coss
Journal of natural products 85 ( 3) 702 -719
22
2022
Exploration of Verticillins in High-Grade Serous Ovarian Cancer and Evaluation of Multiple Formulations in Preclinical In Vitro and In Vivo Models
Elizabeth N Kaweesa , Jaqueline M Bazioli , Herma C Pierre , Daniel D Lantvit
Molecular Pharmaceutics 20 ( 6) 3049 -3059
1
2023
Pharmacokinetics and dose escalation of the heat shock protein inhibitor 17-AAG in combination with bortezomib in relapsed or refractory acute myeloid leukemia
Alison R Walker , Rebecca Klisovic , Jeffrey S Johnston , Yao Jiang
Leukemia & lymphoma 54 ( 9)
1
2013
Nitric oxide mediated inhibition of antigen presentation from DCs to CD4 (+) T cells in cancer and measurement of STAT1 nitration (vol 7, 2017)
Joseph Markowitz , Jiang Wang , Zach Vangundy , Jia You
SCIENTIFIC REPORTS 8
2018
Silencing of miR-221 with anti-microRNA oligonucleotides is an effective therapeutic for hepatocellular carcinoma
Jong Kook Park , Takayuki Kogure , Gerard J Nuovo , Lei He
Cancer Research 71 ( 8_Supplement) 4711 -4711
2011
The neonatal fc receptor is elevated in monocyte-derived immune cells in pancreatic cancer
Justin Thomas , Molly A Torok , Kriti Agrawal , Timothy Pfau
International journal of molecular sciences 23 ( 13) 7066 -7066
8
2022
john C. Byrd Amy J Johnson Christopher C Coss James T Dalton Craig Hofmeister Guido Marcucci Thomas D. Schmittgen Xiaokui Mo Jiang Wang lai wei Mohamed Badawi Tanios Bekaii-Saab Douglas Sborov Wolfgang Sadee Ramiro Garzon Dhruvitkumar (Dhruvit) Sutaria Peter Swaan Erinn M Hade Alexander colevas Robert J. Lee, Ph.D.